Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06574620
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-26
Brief Title:
Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Accelerating the Actionability of Treatment in Resected and Locally Advanced Pancreatic Cancer
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ACCELERATE
Brief Summary:
The goal of this study is to learn if the genetic information and proteins from tumours can help treat pancreatic ductal adenocarcinoma PDAC The main questions it aims to answer are
Is it feasible to obtain genetic test results within a timeframe that can help inform treatment decisions for individuals with PDAC
Can the genetic test results provide information about how a tumour will respond to or resist treatment
Participants will
Receive standard chemotherapy to treat their cancer
Provide samples of their blood tissue and fluid for genetic testing
Visit the clinic every 4 weeks for check-ups and tests
Complete questionnaires every 12 weeks
Is it feasible to obtain genetic test results within a timeframe that can help inform treatment decisions for individuals with PDAC
Can the genetic test results provide information about how a tumour will respond to or resist treatment
Participants will
Receive standard chemotherapy to treat their cancer
Provide samples of their blood tissue and fluid for genetic testing
Visit the clinic every 4 weeks for check-ups and tests
Complete questionnaires every 12 weeks
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None